Assembly Biosciences Executes Reverse Stock Split
Company Announcements

Assembly Biosciences Executes Reverse Stock Split

Assembly Biosciences (ASMB) has released an update.

On February 9, 2024, Assembly Biosciences, Inc. executed a 1-for-12 reverse stock split after receiving stockholder approval. This corporate action, effective immediately, consolidated the number of existing shares, reducing the total from approximately 65.8 million to about 5.5 million, while maintaining each stockholder’s proportional ownership, barring fractional shares which will be compensated in cash. The stock began trading on its new basis on February 12, 2024, aimed at creating a more appealing capital structure and potentially boosting the stock’s market price.

For further insights into ASMB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAssembly Biosciences reports Q3 EPS ($1.51), consensus ($2.02)
Austin AngeloIs ASMB a Buy, Before Earnings?
TheFlyAssembly Biosciences reports interim Phase 1a results from trial of ABI-5366
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App